Program Information
Development and Validation of An Online 2D Dose Verification System for Daily Patient Plan Delivery Accuracy Check
J Zhao1*,W Hu2 , y Xing3 , X Wu4 , Y Li5 , (1) Fudan University Shanghai Cancer Center, Shanghai, Shanghai,(2) Fudan University Shanghai Cancer Center, Shanghai, Shanghai, (3) Fudan univercity shanghai proton and heavy ion center, Shanghai, ,(4) Fudan university shanghai proton and heavy ion center, Shanghai, shagnhai, (5) Department of Medical physics at Shanghai Proton and Heavy Ion Center, Shanghai, Shanghai
Presentations
SU-D-BRC-3 (Sunday, July 31, 2016) 2:05 PM - 3:00 PM Room: Ballroom C
Purpose:
All plan verification systems for particle therapy are designed to do plan verification before treatment. However, the actual dose distributions during patient treatment are not known. This study develops an online 2D dose verification tool to check the daily dose delivery accuracy.
Methods:
A Siemens particle treatment system with a modulated scanning spot beam is used in our center. In order to do online dose verification, we made a program to reconstruct the delivered 2D dose distributions based on the daily treatment log files and depth dose distributions. In the log files we can get the focus size, position and particle number for each spot. A gamma analysis is used to compare the reconstructed dose distributions with the dose distributions from the TPS to assess the daily dose delivery accuracy. To verify the dose reconstruction algorithm, we compared the reconstructed dose distributions to dose distributions measured using PTW 729XDR ion chamber matrix for 13 real patient plans. Then we analyzed 100 treatment beams (58 carbon and 42 proton) for prostate, lung, ACC, NPC and chordoma patients.
Results:
For algorithm verification, the gamma passing rate was 97.95% for the 3%/3mm and 92.36% for the 2%/2mm criteria. For patient treatment analysis,the results were 97.7%±1.1% and 91.7%±2.5% for carbon and 89.9%±4.8% and 79.7%±7.7% for proton using 3%/3mm and 2%/2mm criteria, respectively. The reason for the lower passing rate for the proton beam is that the focus size deviations were larger than for the carbon beam. The average focus size deviations were -14.27% and -6.73% for proton and -5.26% and -0.93% for carbon in the x and y direction respectively.
Conclusion:
The verification software meets our requirements to check for daily dose delivery discrepancies. Such tools can enhance the current treatment plan and delivery verification processes and improve safety of clinical treatments.
Contact Email: